Based on the risk score model of glutathione metabolism-related enzyme genes in thyroid cancer, in a further correlation analysis, we screened the target gene RRM2, whose high expression was significantly and negatively correlated with disease-free survival of patients, from nine candidate genes. The gene discussed is RRM2; the disease is thyroid gland carcinoma.